AbbVievsiRadimed

ABBV and IRMD stock compared: price, dividend, valuation and results, from SEC filings.

IRMD

iRadimed Corporation

$85.35

Value $1.1B

+0.14%
IRMD's page

AbbVie (ABBV) has a market value of $522B and iRadimed (IRMD) $1.1B. Over the last year, with dividends, ABBV moved +30.3% and IRMD +0.4%. The P/E is 50.7 for ABBV and 45.5 for IRMD. Dividend yield: ABBV 2.35%, IRMD 0.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    IRMD$1.1B

    ABBV is 478 times IRMD

  • Revenue, 12 months

    ABBV$66.0B

    IRMD$89M

    ABBV is 739 times IRMD

  • Net income, 12 months

    ABBV$10.3B

    IRMD$24M

    ABBV is 431 times IRMD

  • Operating margin

    ABBV32.2%

    IRMD32.3%

    0.1 points apart

  • ROIC

    ABBV25.7%

    IRMD22.3%

    3.4 points apart

  • P/E

    ABBV50.7

    IRMD45.5

    ABBV is 1.1 times IRMD

  • Dividend yield

    ABBV2.4%

    IRMD0.9%

    1.5 points apart

  • 5-year return

    ABBV+201.5%

    IRMD+133.4%

    68.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.5%

IRMD+133.4%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsIRMDWith dividends
1 year since November 12, 2025+30.3%Price +26.5%+0.4%Price -1.2%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%+115.0%+29.1% a yearPrice +104.8%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%+133.4%+18.5% a yearPrice +111.8%
10 years since November 15, 2016+605.5%+21.6% a yearPrice +369.3%+783.2%+24.3% a yearPrice +701.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieIRMDiRadimed

Valuation

ABBVIRMD
Valuation
Price$295.03$85.35
Market value$522B$1.1B
Enterprise value (EV)$592B$1.0B
P/E50.745.5
P/E, 5-year median57.036.7
P/B–10.3
EV/EBIT27.935.6
Free cash flow yield3.6%2.4%

Results and growth

ABBVIRMD
Results and growth
Revenue, 12 months$66.0B$89M
Net income, 12 months$10.3B$24M
Free cash flow, 12 months$18.9B$26M
Earnings per share, 12 months$5.81$1.87
Revenue growth, year on year8.6%14.4%
Revenue growth a year, past+5.9%over 5 years+21.5%over 5 years
EPS growth a year, past-2.8%over 5 years+73.9%over 5 years

Margins and returns on capital

ABBVIRMD
Margins and returns on capital
Gross margin73.7%75.5%
Operating margin32.2%32.3%
Net margin15.7%26.9%
ROIC25.7%22.3%
ROE–24.0%

Balance sheet

ABBVIRMD
Balance sheet
Cash$10.8B$63M
Total debt$80.9B–
Net debt / EBITDA3.2–
Interest cover7.1×–

Dividends and buybacks

ABBVIRMD
Dividends and buybacks
Dividend yield2.4%0.9%
Dividend per share, 12 months$6.92$0.80
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%–
Shareholder yield2.5%0.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or IRMD

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or iRadimed?

By market value, AbbVie ($522B) is about 478.2 times iRadimed ($1.1B), at today's prices.

How did ABBV and IRMD stock do over the last 10 years?

Since November 15, 2016, ABBV's price moved +369.3% and IRMD's +701.4%. With dividends: ABBV +605.5% (+21.6% a year), IRMD +783.2% (+24.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or IRMD?

The dividend yield at today's price is 2.35% for AbbVie and 0.94% for iRadimed. Over the last twelve months they paid $6.92 and $0.80 per share.

What is the P/E of ABBV and IRMD?

At today's price, the P/E is 50.7 for ABBV and 45.5 for IRMD. The median of the last five years was 57.0 and 36.7, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or iRadimed?

Over the last twelve months, the net margin was 15.7% for AbbVie and 26.9% for iRadimed, and the operating margin 32.2% and 32.3%. Revenue was $66.0B and $89M.

Which is the better investment, AbbVie or iRadimed?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.